Keywords: positive, results, reopro, capture, trial, centocor, halted

Positive Results For ReoPro In CAPTURE Trial

Article | 08 January 1996

Centocor has halted the 1,400-patient CAPTURE trial of its glycoprotein IIb/IIIa antibody, ReoPro (abciximab; 7E3), in refractory unstable angina ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lilly

Go to company listing

Related Drugs

Abciximab

ReoPro

heparin

Aspirin

Bayer

Go to drug listing